Nipco Laxonip Tablets (25gm)
Original price was: ₹150.00.₹130.00Current price is: ₹130.00.
Nipco Laxonip Tablets (25gm) – is used in condition of chronic constipation, Improper and sluggish functioning of intestines and liver. Regulates Bowel Movement, Bloated Stomach and Indigestion.
Composition:
Bryonia Alba, Nux Vomica, Hydrastis Canadensis, Alumina, Cascara S, Senna
Dosage:
4 to 6 tablets 2 times a day or as directed by the physician.
Helps in condition of constipation and establish normal bowel movement.
Brand
Nipco Homeo
Only logged in customers who have purchased this product may leave a review.
Related Products
Helps in easing bowel movement and in relieving of constipation.
Bioforce Blooume 12 Digestisan Drops Indication:
An appetite stimulant. Good for Hyper acidity, indigestion and flatulence.
Composition:
Artemisa Abrotanum 2x
Belladonna 6x
Chionanthus Virginica 6x
Haronga Madgascar 2x
Nux Vomica 6x
Robinia Pseudo 2x
Dosage:
Adults 20 drops in a tablespoon of water, 1/2 an hour before eating, 3 to 5 times daily.
Children: Half the adult dose. Or as directed by the physician.
For piles, burning at anus, swollen piles, sticks, constipation.
Bakson Pilgo Tablets
Indications;
BAKSON’S Pilgo Tablet eases swelled haemorrhoidal veins, relieves piles (blind/bleeding) and treat fissures of anus and worm infestation.
Composition;
Ratanhia
Hamamelis vir
Aesculus hippocastanum
Aloe socotrina
Dosage;
Take 1 tablet 3 times a day for 4 days when bleeding stops take 1 tablet, twice a day for 3-6 months to counter the tendency for piles.
Dr Willmar Schwabe Melilotus Officinalis Q Indications:
Dr Willmar Schwabe India Melilotus Officinalis Mother Tincture is a homoeopathic medicine with a wide range of uses. It can be used for congestion and haemorrhagic conditions in the body and is useful in nervous disorders, congestive headaches, immature spasms, pain and weakness with increased temperature.
Directions For Use:
Take 3-5 drops in half cup water, 2-3 times a day or as directed by the physician.
Reviews
There are no reviews yet.